Dr. Reddy’s Q2 FY24 Results: Pharma major to focus on acquisitions, bringing more generic and innovative products in oncology to India market
Dr. Reddy’s Laboratories on Friday reported its consolidated financial results for the quarter that ended on September 30, 2023. The company recorded profit at Rs 1482.20 crore, up 30 per…
Read More